Clinical Trial Update: Study of Aspirin and TPA in Acute Ischemic Stroke [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating aspirin in combination with tissue plasminogen activator for acute ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Aspirin (Aspirin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Acute Ischemic Stroke | Phase 1 | Status: WITHDRAWN